| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/24/2003 | EP1345609A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 09/24/2003 | EP1345607A1 Therapeutic combination of amlodipine and benazepril / benazeprilat |
| 09/24/2003 | EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/24/2003 | EP1345602A2 Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
| 09/24/2003 | EP1345599A1 Treatment of obsessive compulsive disorder |
| 09/24/2003 | EP1345598A2 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity |
| 09/24/2003 | EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 09/24/2003 | EP1345502A1 Creatine/citric acid compound, method for the production of the same and the use thereof |
| 09/24/2003 | EP1272489B1 Process for preparing crystalline form i of cabergoline |
| 09/24/2003 | EP1259512B1 Pteridine compounds for the treatment of psoriasis |
| 09/24/2003 | EP1252163B1 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 09/24/2003 | EP1242396B1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 09/24/2003 | EP1196419B1 Potassium channel blocking agents |
| 09/24/2003 | EP1150953B1 Indole derivatives and their use as mcp-1 receptor antagonists |
| 09/24/2003 | EP1123109B1 Contulakin-g, analogs thereof and uses therefor |
| 09/24/2003 | EP1100480B1 Muscarinic antagonists in the treatment of presbyopia |
| 09/24/2003 | EP1051415B1 Benzamide derivatives as vasopressin antagonists |
| 09/24/2003 | EP1043308B1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same |
| 09/24/2003 | EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 09/24/2003 | EP0977736B1 Process for preparing pure flupirtin maleate and its modification a |
| 09/24/2003 | EP0946190B1 Methods and compositions for stimulating neurite outgrowth |
| 09/24/2003 | EP0944618B1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
| 09/24/2003 | EP0914122B1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
| 09/24/2003 | EP0904270B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 09/24/2003 | EP0840735B1 Resolution of 1-azabicyclo 2.2.2]octan-3-amine, 2-(diphenylmethyl)-n- 2-methoxy-5-(1-methylethyl)phenyl]methyl] |
| 09/24/2003 | CN1444654A Novel therapeutic molecular variants and uses thereof |
| 09/24/2003 | CN1444600A Use of ADNF polypeptides for enhancing learning and memory |
| 09/24/2003 | CN1444598A Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of immune response to amyloid beta and amyloid deposits |
| 09/24/2003 | CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 09/24/2003 | CN1444589A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 09/24/2003 | CN1444588A Pyrrolo[2,1-b] [1,3] benzothiazepines and their use for preparation of medicaments with antipsychotic activity |
| 09/24/2003 | CN1444583A Method for preparing arylacetyl aminothiazole |
| 09/24/2003 | CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 09/24/2003 | CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor |
| 09/24/2003 | CN1444572A 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
| 09/24/2003 | CN1444570A Non-steroidal inflammation inhibitors |
| 09/24/2003 | CN1444567A 咪唑衍生物 Imidazole derivatives |
| 09/24/2003 | CN1444566A Imidazolyl derivatives |
| 09/24/2003 | CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides |
| 09/24/2003 | CN1444478A Use of celecoxib composition for fast pain relief |
| 09/24/2003 | CN1444472A Plasmid DNA (Lipogenes TM) and nucleas-containing location signal/fusogene conjogates drug encapsulating into targeted liposomes complex |
| 09/24/2003 | CN1443763A Internediate for preparing quinoxaline diketone |
| 09/24/2003 | CN1443554A Wuzidingkun drug-stopping medicine preparation method |
| 09/24/2003 | CN1443543A Medicine composition with the action of relieving alcoholism and protecting liver and its application |
| 09/24/2003 | CN1443533A Application of proanthcyanidin compound in preparation of alcoholism-relieving liver-protecting product |
| 09/24/2003 | CN1122022C Substituted oximes as neurokinin antagonists |
| 09/24/2003 | CN1122019C Tetralines bearing phenyl substituant on aromatic ring and their use in treatment of epilepsy, stroke and brain of spinal trauma |
| 09/24/2003 | CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
| 09/24/2003 | CN1121862C Use of hydrosy asiaticoside for preparing medicine for curing depression |
| 09/23/2003 | US6624288 Conotoxins comprising cyclic peptides used as agonists of calcium channels blockers |
| 09/23/2003 | US6624202 Inhibitors of copper-containing amine oxidases |
| 09/23/2003 | US6624201 High purity (1r,2s,4r)-(−)-2-[(2′-{n,n-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7 -tri-[methyl]-bicyclo [2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof and a process for the preparation of these compounds as well as medicaments containing 1 or more of these compounds and their use |
| 09/23/2003 | US6624195 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 09/23/2003 | US6624192 Diacetylrhein containing aloe-emodin components is subjected to a liquid-liquid partitioning between a polar organic solvent which is only partly miscible with water and an aqueous phase of pH 6.5 to 7.5 and the diacetylrhein is |
| 09/23/2003 | US6624186 Modulators of SKCa, IKCa and BKCa channels. |
| 09/23/2003 | US6624185 Drugs at least one lipid- or triglyceride-lowering active compound; and carriers for lipid metabolism |
| 09/23/2003 | US6624176 Heteroaromatic substituted amides with antagonistic activity to neurokinin 1 receptors |
| 09/23/2003 | US6624175 4-heterocyclic substituted quinoline derivative treats disorderes associated with pathogenic neurokinin-3 receptor, such as anxiety, depression, schizophrenia, obesity, chronic pulmonary obstructive disorder or pain |
| 09/23/2003 | US6624167 Compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and disorders associated with dysfunction of the central and autonomic nervous systems can |
| 09/23/2003 | US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them |
| 09/23/2003 | US6624163 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and Attention Deficit Hyperactivity Disorder |
| 09/23/2003 | US6624161 Administering 2-oxy substituted benzoxazin-5-one derivative to a human or animal for the prevention or treatment of obesity or an obesity related disorder |
| 09/23/2003 | US6624157 Antitumor agents |
| 09/23/2003 | US6623738 Polypeptide consisting of amino acid sequence 2 or 4 which is not cross reactive with mouse, chick nor drosophila neuro-pilin-1 |
| 09/23/2003 | US6623730 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 09/23/2003 | CA2115442C Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist |
| 09/23/2003 | CA2106371C Process for the preparation of ergoline derivatives |
| 09/23/2003 | CA2086654C Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 09/23/2003 | CA2073633C Use of xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas |
| 09/23/2003 | CA2072814C Benzomorphans and their use as pharmaceutical compositions |
| 09/21/2003 | CA2422623A1 Microdialysis methods and applications for treatment and/or prophylaxis of tumors and/or infections in the central nervous system (cns) and/or in other parenchymal organs |
| 09/18/2003 | WO2003076950A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 09/18/2003 | WO2003076658A2 A susceptibility gene for late-onset idiopathic parkinson's disease |
| 09/18/2003 | WO2003076569A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 09/18/2003 | WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase |
| 09/18/2003 | WO2003076455A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein |
| 09/18/2003 | WO2003076443A1 Spiro compounds with npy antagonistic activity |
| 09/18/2003 | WO2003076442A1 Purine derivatives as kinase inhibitors |
| 09/18/2003 | WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament |
| 09/18/2003 | WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases |
| 09/18/2003 | WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076426A2 Pyridinyloxy derivatives as 5-ht receptor ligands |
| 09/18/2003 | WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals |
| 09/18/2003 | WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076420A1 Cyclic amides |
| 09/18/2003 | WO2003076417A2 Oxo-azabicyclic compounds |
| 09/18/2003 | WO2003076416A1 Oxo azabicyclic compounds |
| 09/18/2003 | WO2003076414A2 Aryl substituted pyrimidines and the use thereof |
| 09/18/2003 | WO2003076407A1 Novel chalcone derivatives and uses thereof |
| 09/18/2003 | WO2003076402A1 Therapeutic agent for pain |
| 09/18/2003 | WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076400A1 New inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076399A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions |
| 09/18/2003 | WO2003076398A2 Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors |
| 09/18/2003 | WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 09/18/2003 | WO2003076389A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation |
| 09/18/2003 | WO2003075951A2 Novel application of vaccination against tnf-alpha |
| 09/18/2003 | WO2003075932A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| 09/18/2003 | WO2003075931A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |